Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Fetuin-A and incident diabetes mellitus in older persons.

Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shlipak MG; Health ABC Study..

JAMA. 2008 Jul 9;300(2):182-8. doi: 10.1001/jama.300.2.182.

PMID:
18612115
2.

Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study.

Ix JH, Biggs ML, Mukamal KJ, Kizer JR, Zieman SJ, Siscovick DS, Mozzaffarian D, Jensen MK, Nelson L, Ruderman N, Djousse L.

Circulation. 2012 May 15;125(19):2316-22. doi: 10.1161/CIRCULATIONAHA.111.072751. Epub 2012 Apr 17.

PMID:
22511752
3.

Fetuin-A and change in body composition in older persons.

Ix JH, Wassel CL, Chertow GM, Koster A, Johnson KC, Tylavsky FA, Cauley JA, Cummings SR, Harris TB, Shlipak MG; Health Aging and Body Composition Study..

J Clin Endocrinol Metab. 2009 Nov;94(11):4492-8. doi: 10.1210/jc.2009-0916. Epub 2009 Oct 9.

PMID:
19820014
4.

Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study.

Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA.

Circulation. 2007 May 15;115(19):2533-9. Epub 2007 May 7.

PMID:
17485576
5.

Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo study.

Laughlin GA, Barrett-Connor E, Cummins KM, Daniels LB, Wassel CL, Ix JH.

Diabetes Care. 2013 Jul;36(7):1994-2000. doi: 10.2337/dc12-1870. Epub 2013 Jan 11.

PMID:
23315604
6.

Serum fetuin-A is an independent marker of insulin resistance in Japanese men.

Ishibashi A, Ikeda Y, Ohguro T, Kumon Y, Yamanaka S, Takata H, Inoue M, Suehiro T, Terada Y.

J Atheroscler Thromb. 2010 Sep 30;17(9):925-33. Epub 2010 Jun 11.

PMID:
20543523
7.

Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults.

Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, Grundy SM, Khera A, McGuire DK, de Lemos JA.

JAMA. 2012 Sep 19;308(11):1150-9.

PMID:
22990274
8.

Fetuin-A and BMD in older persons: the Health Aging and Body Composition (Health ABC) study.

Ix JH, Wassel CL, Bauer DC, Toroian D, Tylavsky FA, Cauley JA, Harris TB, Price PA, Cummings SR, Shlipak MG; Health ABC Study..

J Bone Miner Res. 2009 Mar;24(3):514-21. doi: 10.1359/jbmr.081017.

PMID:
19016589
9.

The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study.

Laughlin GA, Cummins KM, Wassel CL, Daniels LB, Ix JH.

J Am Coll Cardiol. 2012 May 8;59(19):1688-96. doi: 10.1016/j.jacc.2012.01.038.

PMID:
22554599
10.

Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.

Kanaya AM, Wassel Fyr C, Vittinghoff E, Harris TB, Park SW, Goodpaster BH, Tylavsky F, Cummings SR.

Arch Intern Med. 2006 Feb 13;166(3):350-6.

PMID:
16476877
11.

Biomarkers of vascular calcification and mortality in patients with ESRD.

Scialla JJ, Kao WH, Crainiceanu C, Sozio SM, Oberai PC, Shafi T, Coresh J, Powe NR, Plantinga LC, Jaar BG, Parekh RS.

Clin J Am Soc Nephrol. 2014 Apr;9(4):745-55. doi: 10.2215/CJN.05450513. Epub 2014 Jan 23.

PMID:
24458076
12.

Association between adiposity in midlife and older age and risk of diabetes in older adults.

Biggs ML, Mukamal KJ, Luchsinger JA, Ix JH, Carnethon MR, Newman AB, de Boer IH, Strotmeyer ES, Mozaffarian D, Siscovick DS.

JAMA. 2010 Jun 23;303(24):2504-12. doi: 10.1001/jama.2010.843.

PMID:
20571017
13.

Plasma fetuin-A concentrations in young and older high- and low-active men.

Jenkins NT, McKenzie JA, Hagberg JM, Witkowski S.

Metabolism. 2011 Feb;60(2):265-71. doi: 10.1016/j.metabol.2010.01.026. Epub 2010 Mar 4.

PMID:
20199782
14.

Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies.

Stefan N, Sun Q, Fritsche A, Machann J, Schick F, Gerst F, Jeppesen C, Joost HG, Hu FB, Boeing H, Ullrich S, Häring HU, Schulze MB.

PLoS One. 2014 Mar 18;9(3):e92238. doi: 10.1371/journal.pone.0092238. eCollection 2014.

PMID:
24643166
15.

Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study.

Liu X, Hamnvik OP, Chamberland JP, Petrou M, Gong H, Christophi CA, Christiani DC, Kales SN, Mantzoros CS.

Metabolism. 2014 Jun;63(6):773-82. doi: 10.1016/j.metabol.2014.03.008. Epub 2014 Mar 15.

PMID:
24726813
16.

Plasma fetuin-A levels and the risk of type 2 diabetes.

Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Häring HU, Schulze MB.

Diabetes. 2008 Oct;57(10):2762-7. doi: 10.2337/db08-0538. Epub 2008 Jul 15.

PMID:
18633113
17.

High-Sensitivity C-Reactive Protein Is Associated With Incident Type 2 Diabetes Among African Americans: The Jackson Heart Study.

Effoe VS, Correa A, Chen H, Lacy ME, Bertoni AG.

Diabetes Care. 2015 Sep;38(9):1694-700. doi: 10.2337/dc15-0221. Epub 2015 Jun 11.

PMID:
26068864
18.

Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy.

Roos M, Oikonomou D, von Eynatten M, Luppa PB, Heemann U, Lutz J, Baumann M, Nawroth PP, Bierhaus A, Humpert PM.

Cardiovasc Diabetol. 2010 Sep 7;9:48. doi: 10.1186/1475-2840-9-48.

PMID:
20822519
19.

Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.

Aroner SA, St-Jules DE, Mukamal KJ, Katz R, Shlipak MG, Criqui MH, Kestenbaum B, Siscovick DS, de Boer IH, Jenny NS, Budoff MJ, Ix JH, Jensen MK.

Atherosclerosis. 2016 May;248:224-9. doi: 10.1016/j.atherosclerosis.2016.03.029. Epub 2016 Mar 22.

PMID:
27038419
20.

Association of Serum Fetuin-A Levels With the Risk of Albuminuria in Middle-Aged and Elderly Chinese.

Lv X, Sun W, Huang X, Chen Y, Ding L, Lin L, Chen Y, Lu J, Xu M, Bi Y, Wang W, Ning G, Xu Y.

J Clin Endocrinol Metab. 2016 Mar;101(3):1235-42. doi: 10.1210/jc.2015-2599. Epub 2016 Jan 12.

PMID:
26756112

Supplemental Content

Support Center